Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Clinical trial NCT02176967 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02176967
- Sponsor
- Children's Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-08
- Primary completion
- 2026-09-30
- Enrollment
- 621
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.